LOGIN
Suprascapular Nerve Blocks for Subacute Adhesive Capsulitis
September 2022
Suprascapular Nerve Blocks for Subacute Adhesive Capsulitis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Randomized controlled trial of suprascapular nerve blocks for subacute adhesive capsulitis
Eur J Phys Rehabil Med . 2022 Aug;58(4):630-637.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Thirty-five patients with subacute adhesive capsulitis were randomized to receive either a suprascapular nerve block with ropivacaine (n=19) or saline (n=16). The primary outcome of this trial was shoulder function using the Constant-Murley Score after 4 weeks. Secondary outcomes assessed range of motion and shoulder pain intensity 4 weeks after the last injection. No significant differences were ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.